FindTrial
Sign In

Value of intraoperative CEUS in diagnosis and treatment of bleeding in HCC ablation

Value of intraoperative CEUS in diagnosis and treatment of bleeding in HCC ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-15006861
Enrollment
Unknown
Registered
2015-07-13
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

Ultrasonography Dept, The Third Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. with HCC diagnosed with pathologic findings or clinical findings; 2. aged 18-80 years; 3. with HCC within the Milan Criteria; 4. with Child-Pugh A-B; 5. PT prolongation =50*10^9/L; 6. able to be treated with RFA or MWA.

Exclusion criteria

Exclusion criteria: 1. unable to be treated with RFA or MWA due to other diseases; 2. unable to be performed with CEUS due to allergy to ultrasonic contrast agent (UCA) or heart/lung dysfunction.

Design outcomes

Primary

MeasureTime frame
The incidence of bleeding;—

Countries

China

Contacts

Public ContactKai Li
bobyman@163.com+86 13632328205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026